| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.030 | 21.890 | 26.935 | 43.180 | 24.898 | 17.296 | 18.842 | 16.100 | 14.287 |
| Total Income - EUR | - | 2.030 | 21.890 | 26.935 | 43.639 | 24.949 | 17.314 | 20.925 | 17.206 | 14.287 |
| Total Expenses - EUR | - | 5.290 | 10.070 | 14.135 | 21.454 | 23.325 | 16.390 | 14.669 | 13.876 | 13.653 |
| Gross Profit/Loss - EUR | - | -3.259 | 11.820 | 12.800 | 22.185 | 1.623 | 924 | 6.257 | 3.330 | 634 |
| Net Profit/Loss - EUR | - | -3.320 | 11.223 | 12.191 | 20.890 | 1.053 | 415 | 5.806 | 2.464 | 286 |
| Employees | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Bujorescu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 619 | 11.167 | 8.112 | 33.050 | 22.018 | 21.656 | 16.441 | 9.209 | 3.891 |
| Current Assets | - | 959 | 13.440 | 20.197 | 29.241 | 11.472 | 614 | 8.239 | 9.803 | 11.540 |
| Inventories | - | 0 | 0 | 746 | 715 | 6.102 | 0 | 0 | 0 | 0 |
| Receivables | - | 934 | 296 | 1.882 | 3.391 | 280 | 561 | 1.656 | 654 | 2.257 |
| Cash | - | 25 | 13.144 | 17.569 | 25.135 | 5.089 | 53 | 6.583 | 9.149 | 9.283 |
| Shareholders Funds | - | -3.209 | 8.069 | 12.803 | 24.952 | 12.409 | 14.628 | 20.061 | 16.555 | 17.032 |
| Social Capital | - | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | 4.787 | 16.539 | 15.505 | 37.490 | 21.081 | 7.642 | 4.619 | 2.457 | 2.601 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Bujorescu S.r.l.